- Home
- GXAI vs PAVM Comparison
GXAI vs PAVM Comparison
Compare GXAI & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GXAI | PAVM |
|---|---|---|
| Founded | 2021 | 2014 |
| Country | United States | United States |
| Employees | N/A | 107 |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.1M | 8.7M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | GXAI | PAVM |
|---|---|---|
| Price | $1.57 | $10.40 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $510.00 |
| AVG Volume (30 Days) | ★ 12.0M | 37.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 52.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,027.00 | N/A |
| Revenue This Year | $42,959.35 | N/A |
| Revenue Next Year | $100.00 | $450.56 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1473.05 | N/A |
| 52 Week Low | $1.00 | $0.21 |
| 52 Week High | $2.96 | $28.44 |
Technical Indicators
Market Signals| Indicator | GXAI | PAVM |
|---|---|---|
| Relative Strength Index (RSI) | 56.25 | 59.74 |
| Support Level | $1.53 | $0.39 |
| Resistance Level | $1.70 | $10.97 |
| Average True Range (ATR) | 0.17 | 0.83 |
| MACD | 0.04 | -0.12 |
| Stochastic Oscillator | 35.77 | 78.82 |
Price Performance
Historical ComparisonAbout GXAI Gaxos.ai Inc.
Gaxos.AI Inc is revolutionizing the way humans interact with artificial intelligence. The company offers applications related to mental and physical well-being, coaching, and gaming. The group is committed to tackling contemporary challenges such as how to live healthier and how to live longer. In addition to offering human-centered solutions, the company uses empathetic and AI technologies.
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.